Literature DB >> 5980571

Radioautographic localization of hydralazine-1-C-14 in arterial walls.

D Moore-Jones, H M Perry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5980571     DOI: 10.3181/00379727-122-31195

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  10 in total

Review 1.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

2.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

3.  Effects of hydralazine on the elasticity of collagen.

Authors:  H P Kraemer; T Nemetschek; F Gross
Journal:  Experientia       Date:  1979-04-15

Review 4.  Clinical pharmacokinetics of hydralazine.

Authors:  T M Ludden; J L McNay; A M Shepherd; M S Lin
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

5.  Haemodynamic effects of hydrallazine and of hydrallazine plus glyceryl trinitrate paste in heart failure.

Authors:  J Mehta; C J Pepine; C R Conti
Journal:  Br Heart J       Date:  1978-08

6.  Autoradiographic study of the distribution of [3H]- and [14C]-hydrallazine in the rat.

Authors:  J R Baker; G R Bullock; I H Williamson
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

7.  Comparative evaluation of the in vitro effects of hydralazine and hydralazine acetonide on arterial smooth muscle.

Authors:  K Barron; O Carrier; K D Haegele; A J McLean; J L McNay; P Du Souich
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

8.  Hydralazine once daily in hypertension.

Authors:  J H Silas; L E Ramsay; S Freestone
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-29

9.  The clinical pharmacology of tolmesoxide. A new vasodilator antihypertensive agent.

Authors:  C P O'Boyle; M Laher; E T O'Brien; K O'Malley; J G Kelly
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 10.  Clinical review: the management of hypertensive crises.

Authors:  Joseph Varon; Paul E Marik
Journal:  Crit Care       Date:  2003-07-16       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.